Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. - Test2 - elhamkhani - TriplyDB

Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.

Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.

http://www.wikidata.org/entity/Q36782415

about

The clinical efficacy of artemether/lumefantrine (Coartem)Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: Individual patient data may be beneficial if only for a subset of trials.Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa.Parents' perceptions, attitudes and acceptability of treatment of childhood malaria with artemisinin combination therapies in ghana.Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.Comparative analysis of the safety and tolerability of fixed-dose artesunate/amodiaquine versus artemether/lumefantrine combinations for uncomplicated falciparum malaria in pregnancy: a randomized open label study.Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.Neuroauditory toxicity of artemisinin combination therapies-have safety concerns been addressed?Protective efficacy of malaria case management and intermittent preventive treatment for preventing malaria mortality in children: a systematic review for the Lives Saved Tool Population pharmacokinetics and pharmacodynamic considerations of amodiaquine and desethylamodiaquine in Kenyan adults with uncomplicated malaria receiving artesunate-amodiaquine combination therapy.Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine Malaria: an update on current chemotherapy.Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children Fixed dose artesunate amodiaquine - a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine.Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic review Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance.Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.Efficacy and Safety of Artesunate-Amodiaquine versus Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium falciparum Malaria in Sentinel Sites across Côte d'Ivoire.Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impact The global pipeline of new medicines for the control and elimination of malaria Therapy of uncomplicated falciparum malaria in Europe: MALTHER - a prospective observational multicentre study.Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola Artesunate Plus Amodiaquine (AS+AQ) Versus Artemether -Lumefantrine (AL) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Sub-Saharan Africa-A Meta-Analysis Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations in the treatment of uncomplicated malaria in two ecological zones in Ghana.Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana.Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine.Multicentre study evaluating the non-inferiority of the new paediatric formulation of artesunate/amodiaquine versus artemether/lumefantrine for the management of uncomplicated Plasmodium falciparum malaria in children in Cameroon, Ivory Coast and Se Factors influencing adverse events reporting within the health care system: the case of artemisinin-based combination treatments in northern Ghana.Reversible audiometric threshold changes in children with uncomplicated malaria Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial.Effect of concomitant artesunate administration and cytochrome P4502C8 polymorphisms on the pharmacokinetics of amodiaquine in Ghanaian children with uncomplicated malaria.A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children.Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi.Safety profile of Coartem: the evidence base.Artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria.Artemether-lumefantrine: an oral antimalarial for uncomplicated malaria in children.Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria.

P2860

Q21034141-9DCA16AF-1E4B-474E-9A1F-BA41755D0540 Q28691509-93A6C86B-C1F3-4725-A682-DC35F30F3D20 Q30567158-76800D7E-0333-49ED-9AAC-B8A6C4E6BA11 Q33399342-D02317DA-B4F3-410F-89AC-18C43F337620 Q33605684-C40843D7-C082-4C1E-ABF3-980BDF30F4AC Q33635019-C2B4A50C-54EF-4358-B40E-B4A927289581 Q33686633-D5321345-3A35-4F34-80C4-EFA967830D32 Q33806574-8830A354-7F1F-4BC2-89D8-5BF59C99F426 Q33841142-E0D5FF16-5E13-463C-A4D1-7F8406AB3EB0 Q33875677-03947999-174D-4FDD-895E-2173289504EB Q33876535-CAA9DD61-5A98-4799-850D-5ECD5B5071A6 Q34221884-D21C0F47-5496-4DDB-B83D-E7BFD85F09C0 Q34433106-9E5164F3-1C3B-4222-87DA-C6995E4D0C2F Q34600201-E985FECF-7768-4069-9390-D3E13FE1E198 Q34996451-6EFCF660-695B-4A91-9C55-49FE2137E061 Q35029488-84FD008C-3C08-48E0-9996-F8ADDCF48076 Q35052961-11FA9BD6-BFB9-4A0F-BF51-9341EBF00C06 Q35154559-58775287-F6A8-4899-B6C4-48ABE5A511A7 Q35245962-BA02091A-5EA9-448A-A2D1-12D515B0CAF6 Q35996318-239D316A-8927-4744-A875-F524070E5C7B Q36080127-95BE0B29-642E-4D1C-92F2-D87A92EBCECB Q36320249-F132AC15-32DB-4632-AFE8-07C8B0A58546 Q36334960-96082201-A9B5-4A7A-9C92-DBCD5C6DEEBC Q36376796-DC677EE0-1D7E-4D71-B361-93229895A304 Q36398146-1968317E-F5E2-4051-8D2E-C510FFE84885 Q36428340-F5085208-72CB-4B96-A693-EC7E2DDC51B5 Q36459535-96BE3E61-3F40-43B8-BCF6-C6B1B0F29B63 Q36507484-7B6276E5-6588-4AFF-9844-8F9DD7C7D3E7 Q36531316-5048C0B7-2A3A-4E3C-8118-038CC81A910E Q36625627-799DAC7F-FAEE-47FF-8298-C1C63B3B194C Q36711788-A863C76D-8360-4A93-BC6D-0F2C35D4E718 Q36812874-264E6AA9-2FF8-48F8-867C-B44BCC4AACBA Q36993430-6F3922CA-3618-4C33-AD5C-CA082ED79DAE Q37059334-8EF36F43-72D9-4958-A2CA-E08DD0DB5331 Q37333155-D4653A3C-E12C-49C1-9481-0E6634DB96F7 Q37349030-3FDC13D9-51E6-4B66-8E53-C31ED33B08CB Q37383298-EE927F34-9F3B-447A-BE78-B4B5F013ED2C Q37388596-209B039F-B540-4F83-801E-7496928E296E Q37579921-6804B513-69C0-4678-BD06-EFE2ABDD9915 Q37857327-1183BEEE-3585-44FD-8FBB-3AE273A15426

P2860

Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.

http://www.wikidata.org/entity/Q36782415

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Amodiaquine-artesunate vs arte ...... trial with one year follow-up.

@en

type

label

Amodiaquine-artesunate vs arte ...... trial with one year follow-up.

@en

prefLabel

Amodiaquine-artesunate vs arte ...... trial with one year follow-up.

@en

P1433

Q36782415-223F31A9-242A-4B8D-AEC4-F7DB06F9FD35

P1476

Q36782415-34094036-53E3-426B-865E-E406FAD12F91

P2093

Q36782415-0CBE3BFB-065C-44F0-A2B2-69FFF6D94014

Q36782415-2FEE2C1C-5047-4EB4-B207-9127D1A0ACFE

Q36782415-34292343-CA1F-479A-B589-751E15B501CA

Q36782415-3A26ED8D-107E-4507-B748-B212D03EA0E2

Q36782415-4701CFDA-05FE-421A-9FC1-EC556E4F29D5

Q36782415-9BB42167-586A-4ED5-A4CD-EA4F0D21A7E9

Q36782415-A0C472AB-378C-48FA-952C-C2BA561B1619

P2860

Q36782415-0146156C-E94C-41B4-8585-2CF49834D4F6

Q36782415-0883971F-5C51-4112-8343-69499D4F10EB

Q36782415-0895D770-1823-4DDD-B835-F75D9BF2EBBA

Q36782415-0954F022-D99A-4212-90A9-17620CCD6BA6

Q36782415-103CED41-E305-4444-99F4-3283F9240FEE

Q36782415-1C935EB6-7D5C-4F0A-B95E-166B81D798C4

Q36782415-22FFACB6-5115-4CA2-B7D7-1054DB6F3463

Q36782415-29DF17FB-3FA3-46A3-9710-202C8D3CDD90

Q36782415-2B69F571-F2D5-4399-A530-733A5FC477C4

Q36782415-2E385C8B-A359-445A-B805-05EC78BE9324

P2888

Q36782415-B619D172-EFDB-4444-A495-D89C94AFA83B

P304

Q36782415-D24B8091-909E-49C7-8E23-9701ABD6C079

P31

Q36782415-29882918-5F7A-4D24-9F58-229AAE867F72

P356

Q36782415-3A89FBF2-9C78-42A9-B902-363B3EA50819

P478

Q36782415-0B0B5172-AFA5-413B-A6E9-4DA4E5239170

P50

Q36782415-740D3991-EC8A-498E-9FA0-FF99F1EC79FA

Q36782415-F722E3FC-737C-4FC2-B429-DB0AF67CEFDB

P577

Q36782415-6C011B74-6191-438A-9146-4E647034A270

P5875

Q36782415-4C814B52-08C5-48BE-8FC6-82F0AFF2783C

P6179

Q36782415-AAE6A9FA-4D0C-454D-AB2B-59FFFBEB2CB6

P698

Q36782415-7A28399F-FA8E-490A-A00B-53DA8B2C5FC5

P921

Q36782415-2ED1168A-5FE5-4403-97D8-73A8C692D4ED

Q36782415-482A8796-748E-4CE4-A3EF-6BA4DE077B9E

Q36782415-D8CDE4EC-D16E-4E95-85BD-47766B2F1C4F

P932

Q36782415-18C1EEF4-0BB9-4A07-B330-A331C8E8B6BB

P356

1475-2875-7-127

P1433

Malaria Journal

P1476

Amodiaquine-artesunate vs arte ...... trial with one year follow-up

@en

P2093

Bamenla Q Goka

http://www.w3.org/2001/XMLSchema#string

Ebenezer V Badoe

http://www.w3.org/2001/XMLSchema#string

Emmanuel D Kitcher

http://www.w3.org/2001/XMLSchema#string

George O Adjei

http://www.w3.org/2001/XMLSchema#string

Lotte C G Hoegberg

http://www.w3.org/2001/XMLSchema#string

Onike P Rodrigues

http://www.w3.org/2001/XMLSchema#string

Roberta Lamptey

http://www.w3.org/2001/XMLSchema#string

P2860

Immunogenicity of amodiaquine in the rat

Detection of antidrug IgG antibodies in patients with adverse drug reactions to amodiaquine

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.

Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.

Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.

Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents.

Amodiaquine induced agranulocytosis and liver damage.

Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.

Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004.

P2888

1475-2875-7-127

P304

127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2875-7-127

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Michael Alifrangis

Jørgen Anders Lindholm Kurtzhals

P577

2008-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5231145

http://www.w3.org/2001/XMLSchema#string

P6179

1028127283

http://www.w3.org/2001/XMLSchema#string

P698

18620577

http://www.w3.org/2001/XMLSchema#string

P921

P932

2478668

http://www.w3.org/2001/XMLSchema#string